114 related articles for article (PubMed ID: 38527564)
1. Fabrication, optimization, and evaluation of lyophilized lacidipine-loaded fatty-based nanovesicles as orally fast disintegrating sponge delivery system.
Moataz El-Dahmy R; Hassen Elshafeey A; Ahmed El-Feky Y
Int J Pharm; 2024 Apr; 655():124035. PubMed ID: 38527564
[TBL] [Abstract][Full Text] [Related]
2. Novel non-ionic surfactant proniosomes for transdermal delivery of lacidipine: optimization using 2(3) factorial design and in vivo evaluation in rabbits.
Soliman SM; Abdelmalak NS; El-Gazayerly ON; Abdelaziz N
Drug Deliv; 2016 Jun; 23(5):1608-22. PubMed ID: 26758033
[TBL] [Abstract][Full Text] [Related]
3. Rapid oral transmucosal delivery of zaleplon-lavender oil utilizing self-nanoemulsifying lyophilized tablets technology: development, optimization and pharmacokinetic evaluation.
Ali SA; Alhakamy NA; Hosny KM; Alfayez E; Bukhary DM; Safhi AY; Badr MY; Mushtaq RY; Alharbi M; Huwaimel B; Alissa M; Alshehri S; Alamri AH; Alqahtani T
Drug Deliv; 2022 Dec; 29(1):2773-2783. PubMed ID: 36036168
[TBL] [Abstract][Full Text] [Related]
4. Investigating the potential of utilizing glycerosomes as a novel vesicular platform for enhancing intranasal delivery of lacidipine.
Naguib MJ; Salah S; Abdel Halim SA; Badr-Eldin SM
Int J Pharm; 2020 May; 582():119302. PubMed ID: 32276091
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous Optimization of Oral and Transdermal Nanovesicles for Bioavailability Enhancement of Ivabradine Hydrochloride.
Naguib MJ; Elsayed I; Teaima MH
Int J Nanomedicine; 2021; 16():2917-2931. PubMed ID: 33911861
[TBL] [Abstract][Full Text] [Related]
6. Lacidipine self-nanoemulsifying drug delivery system for the enhancement of oral bioavailability.
Subramanian N; Sharavanan SP; Chandrasekar P; Balakumar A; Moulik SP
Arch Pharm Res; 2016 Apr; 39(4):481-491. PubMed ID: 26362165
[TBL] [Abstract][Full Text] [Related]
7. Response Surface Optimization of Ultra-Elastic Nanovesicles Loaded with Deflazacort Tailored for Transdermal Delivery: Accentuated Bioavailability and Anti-Inflammatory Efficacy.
Ali AA; Hassan AH; Eissa EM; Aboud HM
Int J Nanomedicine; 2021; 16():591-607. PubMed ID: 33531803
[TBL] [Abstract][Full Text] [Related]
8. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.
Qumbar M; Ameeduzzafar ; Imam SS; Ali J; Ahmad J; Ali A
Biomed Pharmacother; 2017 Sep; 93():255-266. PubMed ID: 28738502
[TBL] [Abstract][Full Text] [Related]
9. Formulation and Characterization of Nanoparticulate Drug Carrier System for Lacidipine.
Dessai AA; Kantak MN; DCruz CEM; Kumar L; Bhide PJ; Shirodkar RK
Assay Drug Dev Technol; 2023 Oct; 21(7):309-324. PubMed ID: 37831909
[No Abstract] [Full Text] [Related]
10. Formulation of Lipid-Based Nanocarriers of Lacidipine for Improvement of Oral Delivery: Box-Behnken Design Optimization,
Kataria D; Zafar A; Ali J; Khatoon K; Khan S; Imam SS; Yasir M; Ali A
Assay Drug Dev Technol; 2022 Jan; 20(1):5-21. PubMed ID: 34978917
[TBL] [Abstract][Full Text] [Related]
11. Design of lipotomes as a novel dual functioning nanocarrier for bioavailability enhancement of lacidipine: in-vitro and in-vivo characterization.
ElKasabgy NA; Elsayed I; Elshafeey AH
Int J Pharm; 2014 Sep; 472(1-2):369-79. PubMed ID: 24979531
[TBL] [Abstract][Full Text] [Related]
12. Tailoring of PEGylated bilosomes for promoting the transdermal delivery of olmesartan medoxomil: in-vitro characterization, ex-vivo permeation and in-vivo assessment.
Albash R; El-Nabarawi MA; Refai H; Abdelbary AA
Int J Nanomedicine; 2019; 14():6555-6574. PubMed ID: 31616143
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of dissolution and oral bioavailability of lacidipine via pluronic P123/F127 mixed polymeric micelles: formulation, optimization using central composite design and in vivo bioavailability study.
Fares AR; ElMeshad AN; Kassem MAA
Drug Deliv; 2018 Nov; 25(1):132-142. PubMed ID: 29275642
[TBL] [Abstract][Full Text] [Related]
14. Development of olmesartan medoxomil optimized nanosuspension using the Box-Behnken design to improve oral bioavailability.
Nagaraj K; Narendar D; Kishan V
Drug Dev Ind Pharm; 2017 Jul; 43(7):1186-1196. PubMed ID: 28271908
[TBL] [Abstract][Full Text] [Related]
15. Self-Emulsifying Drug Delivery System of Simvastatin: Formulation Development, Optimization by Box- Behnken Design,
Verma M; Nanda A; Kumar Y
Recent Pat Drug Deliv Formul; 2018; 12(3):199-211. PubMed ID: 30345934
[TBL] [Abstract][Full Text] [Related]
16. Oleic acid-reinforced PEGylated polymethacrylate transdermal film with enhanced antidyslipidemic activity and bioavailability of atorvastatin: A mechanistic ex-vivo/in-vivo analysis.
El-Say KM; Ahmed TA; Aljefri AH; El-Sawy HS; Fassihi R; Abou-Gharbia M
Int J Pharm; 2021 Oct; 608():121057. PubMed ID: 34461173
[TBL] [Abstract][Full Text] [Related]
17. Rosuvastatin lyophilized tablets loaded with flexible chitosomes for improved drug bioavailability, anti-hyperlipidemic and anti-oxidant activity.
Ahmed TA; Elimam H; Alrifai AO; Nadhrah HM; Masoudi LY; Sairafi WO; El-Say KM
Int J Pharm; 2020 Oct; 588():119791. PubMed ID: 32827673
[TBL] [Abstract][Full Text] [Related]
18. Vardenafil-Loaded Bilosomal Mucoadhesive Sponge for Buccal Delivery: Optimization, Characterization, and In Vivo Evaluation.
Aldawsari MF; Khafagy ES; Alotaibi HF; Abu Lila AS
Polymers (Basel); 2022 Oct; 14(19):. PubMed ID: 36236132
[TBL] [Abstract][Full Text] [Related]
19. Application of Statistical Tooling Techniques for Designing of Carvedilol Nanolipid Transferosomes and its Dermatopharmacokinetic and Pharmacodynamic Studies.
Selvaraj BR; Sridhar SK; Kesavan BR; Palagati S
Pharm Nanotechnol; 2020; 8(6):452-470. PubMed ID: 32988361
[TBL] [Abstract][Full Text] [Related]
20. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization,
Patel MH; Mundada VP; Sawant KK
Drug Dev Ind Pharm; 2019 Aug; 45(8):1242-1257. PubMed ID: 30880488
[No Abstract] [Full Text] [Related]
[Next] [New Search]
